There is no known medicine for COVID-19, and thus, the clinical management is symptomatic. More than 80% people experience mild symptoms who can be treated at home for fever, sore throat, and cough. About 15% patients develop severe illness require O2.
View Article and Find Full Text PDFAim: In this study, we analyzed the risk of developing pre-eclampsia with respect to glutathione S-transferase theta 1 (GSTT1) and glutathione S-transferase mu 1 (GSTM1) genotypes. We also tried to find relationship between genotypes and biochemical parameter change in pre-eclampsia patients.
Methods: In total, 104 pre-eclampsia patients and 200 healthy controls were recruited for the study.
Background: is a ubiquitous free-living bacterium and is responsible for severe nosocomial infections, life-threatening infections in immune compromised persons. The bacterium, along with its natural resistance, can acquire resistance to many antibiotics by a variety of methods.
Method: Therefore, to compare the antibiotic sensitivity pattern of , a total of seventeen isolates of were isolated from different sources; for example environmental sources, frozen food sources, clinical sources and medical waste materials.